Teva Pharmaceutical (Germany) Investor Sentiment

TEV Stock  EUR 20.60  0.20  0.96%   
Roughly 62% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Teva Pharmaceutical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Teva daily returns and investor perception about the current price of Teva Pharmaceutical Industries as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
Global Cellulitis Management Market is likely to witness humungous ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Strs Ohio Buys 561595 Shares of Teva Pharmaceutical Industries ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
Buccal Drug Delivery Market is Estimated to Reach USD 7.13 Billion at a CAGR of 9.8 percent During t...
Google News at Macroaxis
over a year ago at news.google.com         
Azacitidine Market to See Massive Growth by 2029 - openPR
Google News at Macroaxis
over a year ago at news.google.com         
Sequoia Financial Advisors LLC Invests 933000 in Teva ... - MarketBeat
Google News at Macroaxis
over a year ago at news.google.com         
In brief abuse of dominance in United Kingdom - Lexology
Google News at Macroaxis
over a year ago at news.google.com         
As Credit Suisse and First Republic Get Lifelines, Group Sees Plan to Boot Crypto Out of Banking - Y...
Google News at Macroaxis
over a year ago at news.google.com         
Global drugmakers lose positions in Russia due to reduced ... - The Pharma Letter
Google News at Macroaxis
over a year ago at news.google.com         
Teva Pharmaceutical Industries Limited shares were purchased by ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Teva Pharmaceutical launches additional dosage strengths of ... - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
North America Glioblastoma Multiforme Treatment Market Industry ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Aciclovir Market Growth and Global Share 2022 New Report ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Addiction therapeutics market size to increase by USD 9.86 billion ... - PR Newswire
Google News at Macroaxis
over a year ago at news.google.com         
Transdermal Skin Patches Market Future Business Opportunities ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
AION Labs Launches AI Startup for De Novo Antibody Design - Benzinga
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios